Month: December 2024

Business & Finance News

Court Awards Guardant Almost $293M in False Advertising Lawsuit Against Natera Over Cancer Blood Tests
Biotech News

Namilumab Discontinued After Phase II Trial Failure for Pulmonary Sarcoidosis
Biotech Blogs

Biotech IPOs in 2024: Navigating the New Wave of Innovation
Blogs

Food IPOs 2024: A Look at the Companies that Have Gone Public This Year
Biotech News

Invizyne’s IPO Aims to Bring Sustainable Biomanufacturing
Biotech News

Amgen’s GLP-1 Drug MariTide Delivers Solid Weight Loss Results in Trial but Fails to Impress Analysts
Life Science Podcast

Targeting Cancer Drug Resistance with Kairos Pharma’s CEO Dr. John Yu
Biotech News

Jupiter Neurosciences Makes Way in CNS Treatments with $11M IPO
Life Sciences Quizzes & Polls

What Is the Most Transformative Trend in Life Sciences Over the Next Decade?
Clinical Trial News

Novocure’s TTFields Therapy Shows Survival Benefit in Pancreatic Cancer
Biotech Blogs

What Are the Top 10 Diabetes Medications? A Look at Recent Sales Trends
Diagnostics News

Exact Sciences Teams Up with Lil Jon for Cologuard Awareness
Approvals News

Rapiblyk (Landiolol): A New Fast-Acting Option for AFib in the ICU